Sorafenib is an oral multikinase inhibitor with antiangiogenic and antiproliferative properties,
and is used as the first‑line treatment for patients with advanced hepatocellular carcinoma …

Background Lance–Adams syndrome (LAS) is a chronic post-hypoxic myoclonus that may
appear after a period of cerebral hypoxia. Many different antiepileptic drugs (AED) have …

Blinatumomab es el primer anticuerpo biespecífico para células T que ha mostrado eficacia
para conseguir enfermedad mínima residual negativa en pacientes con leucemia …

Background Combination of platinum with a third-generation agent, usually vinorelbine, is
considered the standard first line in non-small-cell lung cancer (NSCLC). Purpose To …

Background Pegylated liposomal doxorubicin (PLD) is indicated in ovarian cancer patients
who have failed firstline platinum based chemotherapy. Currently, there are no clinical or …

Background Raltitrexed is approved for the treatment of advanced colorectal cancer when
there is a contraindication to fluoropyrimidines. Compared to different regimens of 5 …

Background Pegylated liposomal doxorubicin (PLD) can be used for the treatment of
advanced ovarian cancer in women who have failed a first-line platinum-based …

Objective: To analyse anticholinergic agent consumption in HIV patients 50 years or older; to
determine anticholinergic risk using the Anticholinergic Cognitive Burden Scale (ACB) and …

Background The Phase III TOGA study confirmed an increased survival for patients with
HER2-positive advanced gastric cancer (AGC) treated with trastuzumab in combination with …

Background Alemtuzumab is a monoclonal antibody directed against the CD52 antigen on T-
and B-lymphocytes indicated in adult patients with relapsing remitting multiple sclerosis …